miR-223-3p在不同分期的糖尿病肾脏疾病血浆中的表达差异及意义

何君一; 李斓; 李嵘; 黄云华; 杨秋萍; 吴亚楠; 张丽华

miR-223-3p在不同分期的糖尿病肾脏疾病血浆中的表达差异及意义

1. 昆明医科大学第一附属医院老年内分泌科
2. 昆明医科大学第一附属医院糖尿病科
3. 云南省第一人民医院肾内科
4. 昆明医科大学第一附属医院内分泌科一科

基金项目:

基金：国家自然科学基金资助项目 (81560126); 云南省科技厅-昆明医科大学应用基础研究联合专项基金资助项目[2017FE468 (-042) ]; 云南省应用基础研究基金资助项目 (2016FB127); 成都医学院科研基金资助项目 (CYZ15-08);

计量
- 文章访问数: 1771
- HTML全文浏览量: 635
- PDF下载量: 86
- 被引次数: 0
出版历程
- 收稿日期: 2018-02-23

Expression and Significance of Plasma miR-223-3p in Diabetic Kidney Diseaseat Different Stages

Funds:

摘要

摘要: 目的探索mi R-223-3p在糖尿病肾脏疾病 (DKD) 患者血浆中的表达情况及其临床意义.方法应用实时荧光定量PCR技术 (q RT-PCR) 分别检测糖尿病无肾病组60例 (DM组) 、糖尿病早期肾病组60例 (Micro-DKD组) , 糖尿病临床期肾病组60例 (Macro-DKD) 和正常健康对照组60例 (Control组) 血浆中mi R-223-3p的表达变化, 分析其与糖尿病肾脏疾病的关系;运用基因预测分析软件预测mi R-223-3p靶基因.结果与Control组相比, 其余3组患者血浆中mi R-223-3p的表达水平明显下降 (P<0.001) , 随着病情严重程度的进展, 血浆中mi R-223-3p的表达水平下降更加明显.生物信息学分析得出IL6ST和PRKCE为mi R-223-3p的靶基因.结论 mi R-223-3p表达水平在DKD患者血浆中表达下降并与严重程度有关, 可能通过调控其下游靶基因在糖尿病肾脏疾病发生过程中起重要作用.
- miR-223-3p /
- 糖尿病肾脏疾病 /
- 实时荧光定量PCR /
- 靶基因
Abstract: Objective To explore the expression of miR-223-3 p in the plasma of patients with diabetic kidney disease and its clinical significance. Me thods The expression levels of plasma miR-223-3 p in normoalbuminuric group (DM) , microoalbuminuria group (Micro-DKD) , macroalbuminuria group (Macro-DKD) and healthy controls were measured by quantitative real-time polymerase chain reaction (q RT-PCR) . To analysis the relationship with clinical pathological parameters, target genes of miR-223-3 p were predicted with bioinformatics software. Re s ults The levels of miR-223-3 p in the plasma of the remaining three groups were significantly lower than those in the healthy controls (P <0.001) , and the decrease was positively correlated with the severity of the disease. The potential target genes of miR-223-3 p identified by bioinformatics softwares include IL6 ST and PRKCE. Conclus ion The expressionof miR-223-3 pin diabetic kidney disease (DKD) patients' plasma decreased and was positively correlated with the severity of the disease. It may play an important role in the development and progression of diabetic kidney disease through its target genes.
- Diabetic kidney disease /
- miR-223-3p /
- Target genes /
- Quantitative real-time PCR

HTML全文

参考文献(24)

[1]	[1]BARTEL D P.Micro RNAs:Target recognition and regulatory functions[J].Cell, 2009, 136 (2) :215-233.
[2]	[2]ZHANG L, RONG L, HE J, et al.Co-expression analysis among micro RNAs, long non-coding RNAs, and messenger RNAs to understand the pathogenesis and progression of diabetic kidney disease at the genetic level[J].Methods, 2017, 124 (5) :46-56.
[3] 中华医学会糖尿病学分会.中国2型糖尿病防治指南 (2013年版) [J].中华内分泌代谢杂志, 2014, 30 (10) :447-498.
[4]莫一菲, 周健, 贾伟平.国际糖尿病联盟2012年全球2型糖尿病指南解读[J].中国医学前沿杂志 (电子版) , 2012, 4 (11) :70-77.
[5]	[5]CAON B L, DIAZH N, CALVO HUEROS J I, et al.Incidence of cardiovascular disease and validity of equations of coronary risk in diabetic patients with metabolic syndrome[J].Med Clin (Barc) , 2007, 128 (14) :529-535.
[6] 中华医学会糖尿病学分会微血管并发症学组.糖尿病肾病防治专家共识 (2014年版) [J].中国糖尿病杂志, 2014, 6 (11) :792-801.
[7]	[7]LONG J, WANG Y, WANG W, et al.Micro RNA-29c is a signature micro RNA under high glucose conditions that targets Sprouty homolog 1, and its in vivo knockdown prevents progression of diabetic nephropathy[J].J Biol Chem, 2011, 286 (13) :11837-11848.
[8]	[8]WANG Q, WANG Y, MINTO A W, et al.Micro RNA-377is upregulated and can lead to increased fibronectin production in diabetic nephropathy[J].Faseb J, 2008, 22 (12) :4126-4135.
[9]	[9]KATO M, ARCE L, WANG M, et al.A micro RNA circuit mediates transforming growth factor-beta1 autoregulation in renal glomerular mesangial cells[J].Kidney Int, 2011, 80 (4) :358-368.
[10]	[10]CHUNG A C, LAN H Y.Micro RNAs in renal fibrosis[J].Front Physiol, 2015, 6:50.doi:10.3389/fphys.2015.00050.
[11]袁牧, 王昌留, 王一斐, 等.超氧化物歧化酶的研究进展[J].中国组织化学与细胞化学杂志, 2016, 25 (6) :550-558.
[12]	[12]ZHANG C, WANG C, CHEN X, et al.Expression profile of micro RNAs in serum:A fingerprint for esophageal squamous cell carcinoma[J].Clin Chem, 2010, 56 (12) :1871-1879.
[13]	[13]WANG H, PENG W, OUYANG X, et al.Circulating micro RNAs as candidate biomarkers in patients with systemic lupus erythematosus[J].Transl Res, 2012, 160 (3) :198-206.
[14]	[14]XU J, YAO Q, HOU Y, et al.mi R-223/Ect2/p21 signaling regulates osteosarcoma cell cycle progression and proliferation[J].Biomed Pharmacother, 2013, 67 (5) :381-386.
[15]	[15]HUANG K, DONG X, SUI C, et al.mi R-223 suppresses endometrial carcinoma cells proliferation by targeting IGF-1R[J].Am J Transl Res, 2014, 6 (6) :841-849.
[16]	[16]WALSH C A, QIN L, TIEN J C, et al.The function of steroid receptor coactivator-1 in normal tissues and cancer[J].Int J Biol Sci, 2012, 8 (4) :470-485.
[17]刘秉文, 陈俊杰.医学分子生物学[M].北京:中国协和医科大学出版社, 2006:191-604.
[18]戴国华, 宋宪波, 马培泽, 等.微小RNA-223-3p通过调节Rps6kb1/HIF-1α信号通路抑制缺血心肌微血管内皮细胞血管新生[J].中华心血管病杂志, 2014, 42 (12) :1039-1047.
[19]李星军, 王哲敏, 郭友成, 等.血清VEGF、IL-6、Cys-C水平与2型糖尿病肾脏疾病的关系研究[J].检验医学与临床, 2015, 12 (21) :3207-3208.
[20]	[20]TANAKA T, NARAZAKI M, KISHIMOTO T.IL-6 in inflammation, immunity, and disease[J].Cold Spring Harb Perspect Biol, 2014, 6 (10) :a016295.
[21]	[21]WOLF J, ROSE-JOHN S, GARBERS C.Interleukin-6and its receptors:A highly regulated and dynamic system[J].Cytokine, 2014, 70 (1) :11-20.
[22]	[22]WUEEST S, ITEM F, LUCCHINI F C, et al.Mesenteric fat lipolysis mediates obesity-associated hepatic steatosis and insulin Resistance[J].Diabetes, 2016, 65 (1) :140.
[23]	[23]DEKKER L V, PARKER P J.Protein kinase C--a question of specificity[J].Trends in Biochemical Sciences, 1994, 19 (2) :73.
[24]	[24]BASTA P, STRICKLAND M B, HOLMES W, et al.Sequence and expression of human protein kinase C-epsilon[J].Biochimica et Biophysica Acta (BBA) -Gene Structure and Expression, 1992, 1132 (2) :154-160.

相关文章(20)

[1]	牛玲, 马蓉, 张程, 苗翠娟, 唐艳, 刘方, 李博一. 2型糖尿病合并骨质疏松患者PTH及ER基因多态性分析, 昆明医科大学学报.
[2]	曾慧娟, 田波, 袁红伶, 何杰, 李冠羲, 茹国佳, 许敏, 詹东. 机器学习算法构建慢性肾脏病伴高血压或糖尿病的预测模型, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20240315
[3]	谭洪, 殷和佳, 李妍, 胡琴, 李斓, 任遵丹, 石柔. DDAH1基因836A/T多态性与云南地区汉族2型糖尿病肾脏疾病的相关性分析, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20230621
[4]	江岩, 赵正科, 王光彦, 许连刚, 李梦蝶, 王茂繁, 龙双梅, 刘蛟, 钱晋. 血清GAD、ICA及 C-P联合检测对1型糖尿病的诊断价值, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20220416
[5]	阮愕舒, 王烁, 苏惠, 尹凤琼, 钱忠义, 杨建宇. 人参皂苷Rg1对2型糖尿病大鼠的肾脏保护作用, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20210625
[6]	罗景梅, 李灿晖, 李斓, 林婕, 张婧容, 张丽华. 血浆miR-1181在2型糖尿病患者表达水平变化和意义, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20211019
[7]	张旭祥, 李雯, 王芳, 林梦洁, 李红, 张丽, 念馨. APOE基因多态性与云南傣族2型糖尿病相关性, 昆明医科大学学报.
[8]	戴海龙, 张星, 潘云, 冯晓岚, 卢祥婷, 光雪峰, 尹小龙. 冠心病患者外周血单核细胞中miR-125a-5p、miR-193b的表达, 昆明医科大学学报.
[9]	李佳丽, 周晓伟, 郭伟昌, 陈婕, 张帆, 李会芳. GAS6基因多态性及其血浆水平与昆明地区汉族糖尿病肾脏疾病的相关性, 昆明医科大学学报.
[10]	杜飞, 李榕, 何睿, 曾水芹, 段开文, 李承文. 实时定量PCR检测白色念珠菌方法学的建立, 昆明医科大学学报.
[11]	陶文玉. mTOR和VEGF基因表达在糖尿病大鼠肾损伤中的相关性, 昆明医科大学学报.
[12]	曹永梅, 吕毅, 刘玉静, 李颖川. miR-200及其靶基因ZEB1/2在急性肺损伤后早期肺纤维化中上皮-间质转化(EMT)过程, 昆明医科大学学报.
[13]	马卿鑫. miRNA-192在人体手术切除肺癌组织中的表达及临床意义研究, 昆明医科大学学报.
[14]	陈波. MiR-10b及其前体和Dicer在乳腺癌中的表达, 昆明医科大学学报.
[15]	安新焕. ACE和eNOS 2个基因多态性并存与糖尿病肾病的相关性, 昆明医科大学学报.
[16]	李会芳. 糖尿病肾病易感基因位点多态性的交互作用, 昆明医科大学学报.
[17]	陈波. hsa-miR-126的靶基因预测及功能分析, 昆明医科大学学报.
[18]	吴云鼎. 实时定量PCR的数据归一化方法, 昆明医科大学学报.
[19]	李会芳. 佤族人群CCR5基因59029G/A多态性与糖尿病前期和糖尿病的相关性研究, 昆明医科大学学报.
[20]	李梅蕊. PC-1基因多态性与2型糖尿病及糖尿病肾病的相关性研究, 昆明医科大学学报.